SNDX
Syndax Pharmaceuticals Inc
18.20$
+0.6%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -558.9% | – | – | – | |
| – | +40.0% | +323.8% | -14.6% | +2.6% | +17.9% | -3.3% | -51.7% | -23.3% | -63.6% | -33.3% | -25.0% | |
| – | +72.0% | +21.3% | +15.8% | +13.8% | -3.2% | +50.8% | +47.0% | +20.3% | +93.2% | +39.0% | +10.4% | |
| – | +1,144.7% | -0.6% | -10.0% | +9.3% | -3.3% | +57.3% | +36.8% | +8.1% | – | – | – | |
| – | +2,542.5% | -80.0% | +163.2% | -103.9% | – | – | – | – | +1,823.9% | -58.3% | -697.7% | |
| – | +1,125.0% | +432.7% | -67.8% | +122.6% | -31.0% | +0.0% | +0.0% | +74.4% | -100.0% | – | – | |
| – | -3,366.4% | -70.2% | -7.4% | – | -75.1% | -1,215.2% | -71.3% | +355.5% | – | -286.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,458,466.7% | -38.1% | -50.1% | -41.9% | +81.7% | +896.5% | -91.3% | – | – | – | – | |
| – | -164.3% | – | – | +0.0% | +0.0% | +0.0% | -206.4% | +0.0% | -100.0% | – | – | |
| – | +522.6% | -29.9% | +39.7% | -79.2% | +81.6% | +965.5% | -61.1% | +45.4% | +53.3% | +33.8% | -96.1% | |
| – | – | -95.0% | +1,602.9% | -112.4% | – | – | +17.8% | -238.3% | – | -163.9% | – | |
| – | – | – | – | – | – | – | – | -561.7% | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.